Please use this identifier to cite or link to this item:
|Title:||A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness.|
|Authors:||Judd, F K;Moore, K;Norman, Trevor R;Burrows, Graham D;Gupta, R K;Parker, G|
|Affiliation:||University of Melbourne, Department of Psychiatry, Austin Hospital, Heidelberg, Victoria.|
|Citation:||The Australian and New Zealand Journal of Psychiatry; 27(1): 49-55|
|Abstract:||The antidepressant efficacy and side effect profile of a fixed dose of 20 mg/day of fluoxetine, a specific serotonin reuptake inhibitor, were compared to those of amitriptyline. Fifty-eight patients with DSM-III-R depression were randomly assigned to receive either fluoxetine or amitriptyline. Fifty-six patients (fluoxetine N = 23, amitriptyline N = 23) completed the 6 week study. Comparable antidepressant efficacy was demonstrated for the two drugs. Patients taking fluoxetine reported less side-effects than those taking amitriptyline.|
|Internal ID Number:||8481170|
Amitriptyline.adverse effects.therapeutic use
Depressive Disorder.drug therapy.psychology
Fluoxetine.adverse effects.therapeutic use
Suicide.prevention & control.psychology
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.